Sergio Quezada
Fondateur chez ACHILLES THERAPEUTICS PLC
Fortune : 288 901 $ au 30/04/2024
Provenance du réseau au premier degré de Sergio Quezada
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University College London
226
| College/University | Other Consumer Services | 226 |
| Public Company | Pharmaceuticals: Major | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sergio Quezada via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer Founder Director/Board Member Founder | |
| Imperial College London | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| King's College London | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree | |
| BP PLC | Integrated Oil | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| London Business School | College/University | Corporate Officer/Principal Masters Business Admin Human Resources Officer | |
| University of Surrey | College/University | Graduate Degree Undergraduate Degree | |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| The University of Manchester | College/University | Director/Board Member Graduate Degree | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| The Royal College of Surgeons of England | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The Open University | College/University | Doctorate Degree Corporate Officer/Principal | |
| Bayes Business School | College/University | Graduate Degree Graduate Degree | |
| Royal Free Hospital Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| The Institute for Fiscal Studies (Research Firm) | Investment Managers | Economist Analyst-Equity | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| The University of Southampton | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
University College London Hospitals NHS Foundation Trust
 University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services University College London Hospitals NHS Foundation Trust provides first-class acute and specialist services in six hospitals in central London, UK. The British company's mission is to deliver top-quality patient care, excellent education, and world-class research. The company also offers events, classes, and workshops at the Macmillan Support and Information Service (MSIS) and an audiological service for GPs who would like to refer patients for age-related audiological assessments. Additionally, the company provides information about the sarcoma service and hearing therapists who work with adults who have hearing loss and associated disorders, such as tinnitus and hyperacusis, and other forms of hypersensitivity. The company is ultimately controlled by the Government of United Kingdom. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| London School of Economics & Political Science | College/University | Masters Business Admin Graduate Degree | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Analyst-Equity | |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| TISSUE REGENIX GROUP PLC | Medical Specialties | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Yale University Dramatic Association | Director/Board Member | ||
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Syndicate Room Ltd.
 Syndicate Room Ltd. Investment ManagersFinance Syndicate Room Ltd (Syndicate Room) is a venture capital firm founded in 2011 by Gonçalo de Vasconcelos and Tom Britton. The firm is headquartered in Cambridge, UK. | Investment Managers | Private Equity Investor | |
Oxford Seed Fund /Venture Capital/
 Oxford Seed Fund /Venture Capital/ Investment ManagersFinance Oxford Seed Fund /Venture Capital/ is a venture capital arm of Saïd Business School, founded in 2012. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Sapienza University of Rome | College/University | Undergraduate Degree | |
McKinsey & Company Holdings Ltd.
 McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Part of McKinsey & Co., Inc., McKinsey & Company Holdings Ltd. is a consulting firm that partners with leaders on strategy, innovating to net zero, leading with tech, and building capabilities for a sustainable, inclusive, growing future. The company is based in London, UK. The British company specializes in Consumer Packaged Goods and has conducted research, articles, and reports on the changes that matter most for the challenges and opportunities ahead. The company was founded in 2011 by Brian K. Stafford. | Financial Conglomerates | Corporate Officer/Principal | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| The University of Reading | College/University | Undergraduate Degree | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| University of Mysore | College/University | Undergraduate Degree | |
University Hospitals Coventry & Warwickshire NHS Trust
 University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Warwick | College/University | Corporate Officer/Principal | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
High Speed Two (HS2) Ltd.
 High Speed Two (HS2) Ltd. Other TransportationTransportation High Speed Two (HS2) Ltd. provides rail transportation services. It engages in developing and promoting the high speed rail network. The firm offers Y-shaped rail network providing direct high speed rail links between London and Birmingham. The company was founded in January 2009 and is headquartered in London, the United Kingdom. | Other Transportation | Director/Board Member | |
| London First | Miscellaneous Commercial Services | Chief Executive Officer | |
| House of Lords | General Government | Corporate Officer/Principal | |
Heathrow Southern Railway Ltd.
 Heathrow Southern Railway Ltd. RailroadsTransportation Heathrow Southern Railway Ltd. is a privately financed proposal for southern access to Heathrow Airport. The private company is based in London, UK. The British company aims to expand train connections across southern England and reduce road journeys to rail. The railway will mainly be in tunnel, filling a missing link in the existing network. The company estimates that each year, the railway will reduce the number of road journeys by around 3 million and avoid the release of 2 tons of NOx and 8,600 tons of CO2 into the atmosphere. The railway will improve connectivity between Surrey and Heathrow for commuters, creating a new route from Basingstoke, Guildford, and Woking via Heathrow Airport to Old Oak Common and Paddington. | Railroads | Director/Board Member | |
| VALUE AND INDEXED PROPERTY INCOME TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
Peabody Pension Trust Ltd.
 Peabody Pension Trust Ltd. Services to the Health IndustryHealth Services Peabody Pension Trust Ltd. engages in the provision of housing services. It includes rent and service charges, safer communities, resident involvement, benefits and budgeting, homeowner information, health and safety, and succession and assignment services. It also offers employment and training; health and wellbeing; digital training; older people; youth; volunteering; events and activities; and fundraising programmes. The company was founded by George Peabody in 1862 and is headquartered in London, the United Kingdom. | Services to the Health Industry | Director/Board Member |
Statistiques
Internationale
| Royaume-Uni | 35 |
| Etats-Unis | 10 |
| Israël | 3 |
| Japon | 2 |
| Îles Cayman | 2 |
Sectorielle
| Consumer Services | 19 |
| Health Technology | 13 |
| Finance | 6 |
| Health Services | 5 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 207 |
| Corporate Officer/Principal | 152 |
| Undergraduate Degree | 57 |
| Independent Dir/Board Member | 47 |
| Chairman | 40 |
Relations les plus connectées
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| David Knox | 27 |
| Junaid Bajwa | 18 |
| DeAnne Shirley Julius | 17 |
| Derek DiRocco | 17 |
| Julie O'Neill | 16 |
| Bernhard R. M. Ehmer | 16 |
| Carsten Boess | 15 |
| Sarah Whitney | 15 |
| Ian Dato | 13 |
| José-Alain Sahel | 13 |
| Christopher Mason | 12 |
| Mark Lowdell | 12 |
| Julia Prescot | 11 |
| Dame Angela Strank | 11 |
- Bourse
- Insiders
- Sergio Quezada
- Connexions Sociétés
